THE SOCIETY IS A NATIONAL ALLIANCE OF LEADING ACADEMIC AND COMMUNITY BASED URO-ONCOLOGISTS COMMITTED TO THE FOLLOWING - TO FURTHER UROLOGY RESEARCH AND PHARMACEUTICAL TRIALS, - TO OFFER & PROVIDE FOR THE BEST POSSIBLE APPROACH TO DISEASE EDUCATION AND MANAGEMENT PROVIDING FOR BETTER PATIENT OUTCOMES, - TO PROVIDE EDUCATION FOR THE PROFESSION TO FURTHER THE LEARNINGS CONDUCTED THROUGH THE PROFESSION, - AND TO ALLOW CLINICIANS TO BE AWARE OF EXISTING RESEARCH, WHICH ADVANCES FURTHER CLINICAL EDUCATION AND HYPOTHESES.
Reported officers (all unpaid)
No paid executives reported in 2023. SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM reported 10 unpaid officers and board members on its 990.
Revenue and expenses over time
SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM reported revenue and expenses across 2 filing years.
What Medical Research executives earn in Illinois
SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization in Illinois earns a median of $107,438.
These are medical research sector-wide figures, not this organization's reported pay. Based on 73 organizations across 73 filings (2022 – 2024).
See full Medical Research pay data for Illinois →Common questions about SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM
What are SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM's revenue and expenses?
In 2023, SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM reported $554k in total revenue and $270k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.